Cite
HARVARD Citation
Brook, M. et al. (2022). Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients. BMJ open. 12 (4), p. . [Online].